Ignite Creation Date:
2025-12-25 @ 1:01 AM
Ignite Modification Date:
2025-12-25 @ 11:15 PM
Study NCT ID:
NCT01182493
Status:
COMPLETED
Last Update Posted:
2018-03-12
First Post:
2010-08-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy
Sponsor:
Medtronic Diabetes
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EUR05 / CEP234
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None